The fintech unicorn has gone beyond payments into neobanking and facilitating loans and insurance. The dream is to become the only financial platform a business will ever need
As Bharat Biotech's Covaxin shows an interim efficacy of 81 percent, Forbes India traces the career of the founder, whose entrepreneurial journey has seen a successful track record of developing vaccines in India for the world
The first woman pilot hired by Air India, Harpreet A De Singh is now charged with turning around the fortunes of its subsidiary Alliance Air
Will Sebi's new recommendations make public listings easier for India's internet-based startups?
If inflation proves to be sticky, rising costs of capital for the government, companies and individuals could also restrict infrastructure spending and slow down private sector capex cycle
As the government prepares to vaccinate senior citizens and persons with comorbidities, Forbes India deconstructs the immunisation plan and looks at how private sector involvement can speed up the current laggard pace of Covid-19 vaccinations
Six years after exiting his ride-hailing service venture, he starts Zolve—a branchless digital banking services provider—that offers local access to credit and insurance at affordable rates to those who traverse the globe
Nearly six months after it struck a deal with Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, the company is awaiting permission to administer the Sputnik V vaccine in India
How, at 55, the founder of Digit Insurance built a unicorn in three years
The MD & CEO, who will relocate to Germany later this year, turned around the fortunes of the company by ensuring a diversified portfolio, launching attractive products, and addressing quality and cost issues
When the world's second biggest sportswear brand Adidas announced plans to scoop up Reebok, the third largest, all eyes were on it. 15 years later, it seems like a bad decision in hindsight. We decode why the gambit didn't pay off in India and globally